IFLR1000

Abris Capital Partners acquisition of ITP

13/7/2018
Private acquisition
Select tab

Announced

13/7/2018

Overview:

  • Abris Capital Partners has acquired a strategic stake in ITP, a Polish company that sells aesthetic medicine products in 45 countries.

Rajeeb Gurung - Researcher

Jurisdiction:

Poland

Deal type:

Private acquisition

Practice area:

M&A

Industry sectors:

Healthcare
Pharmaceuticals and life sciences

Firms:
CMS Cameron McKenna Nabarro Olswang Pośniak i Bejm

Party: Abris Capital Partners (Acquirer)

Lawyer: Rafał Zwierz

Wierzbowski Eversheds Sutherland

Party: ITP (Seller)

Related deals